Cargando…
COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria
Autores principales: | Gerber, Gloria F., Yuan, Xuan, Yu, Jia, Cher, Benjamin A. Y., Braunstein, Evan M., Chaturvedi, Shruti, Brodsky, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099541/ https://www.ncbi.nlm.nih.gov/pubmed/33945618 http://dx.doi.org/10.1182/blood.2021011548 |
Ejemplares similares
-
Severe Hemolysis in a COVID-19 Patient with Paroxysmal Nocturnal Hemoglobinuria
por: Otieno, Steve Biko, et al.
Publicado: (2021) -
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated?
por: Bellido, M., et al.
Publicado: (2012) -
ADP: the missing link between thrombosis and hemolysis
por: Gerber, Gloria F., et al.
Publicado: (2023) -
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria
por: Lazana, Ioanna, et al.
Publicado: (2023) -
Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria
por: Wong, Raymond Siu Ming, et al.
Publicado: (2023)